STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools Appoints Alex Kim as Chief Financial Officer

07 11 2024 07:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

31 10 2024 07:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Reports Third Quarter 2024 Financial Results

30 10 2024 15:01:01 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

16 10 2024 07:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform

24 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)

18 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

26 8 2024 07:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

06 8 2024 15:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Senior Leadership Changes

31 7 2024 15:02:00 提供 Nasdaq GlobeNewswire

Standard BioTools Reports Second Quarter 2024 Financial Results

31 7 2024 15:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

17 7 2024 07:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

28 5 2024 15:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

22 5 2024 15:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools Reports First Quarter 2024 Financial Results

08 5 2024 15:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

25 4 2024 07:01:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

25 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

08 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

03 4 2024 15:01:13 提供 Nasdaq GlobeNewswire

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

18 3 2024 07:12:23 提供 Nasdaq GlobeNewswire